Evidence map›Paper›PMID 40674425›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2025

Neutron and time-resolved X-ray crystallography reveal the substrate recognition and catalytic mechanism of human Nudix hydrolase MTH1.

Keisuke Hirata, Kana Fujimiya, Andreas Ostermann, Tobias E Schrader, Takeshi Hiromoto, Masataka Goto, Takao Arimori, Yu Hirano, Katsuhiro Kusaka, Taro Tamada and 1 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Keisuke Hirata *Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto 862-0973, Japan.
Kana Fujimiya *School of Pharmacy, Kumamoto University, Kumamoto 862-0973, Japan.
Andreas OstermannHeinz Maier-Leibnitz Zentrum, Technische Universität München, Garching 85748, Germany.ORCID 0000-0002-1477-5590
Tobias E SchraderForschungszentrum Jülich GmbH, Jülich Centre for Neutron Science at Heinz Maier-Leibnitz Zentrum, Garching 85748, Germany.ORCID 0000-0001-5159-0846
Takeshi HiromotoInstitute for Quantum Life Science, National Institutes for Quantum Science and Technology, Chiba 263-8555, Japan.ORCID 0000-0002-8410-5111
Masataka GotoGraduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto 862-0973, Japan.
Takao ArimoriLaboratory for Protein Synthesis and Expression, Institute for Protein Research, The University of Osaka, Osaka 565-0871, Japan.ORCID 0000-0002-6063-5572
Yu HiranoInstitute for Quantum Life Science, National Institutes for Quantum Science and Technology, Chiba 263-8555, Japan.ORCID 0000-0002-3007-6052
Katsuhiro KusakaNeutron Industrial Application Promotion Center, Comprehensive Research Organization for Science and Society, Ibaraki 319-1106, Japan.
Taro TamadaInstitute for Quantum Life Science, National Institutes for Quantum Science and Technology, Chiba 263-8555, Japan.ORCID 0000-0003-1419-8022
Teruya NakamuraGraduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto 862-0973, Japan.ORCID 0000-0003-2013-3057

Funding

MEXT | Japan Society for the Promotion of Science (JSPS) 15H01050MEXT | Japan Society for the Promotion of Science (JSPS) 18K06600MEXT | Japan Society for the Promotion of Science (JSPS) 24K01966
6 · The paper itself

Abstract

Human MTH1, a Nudix enzyme, hydrolyzes several oxidized nucleotides such as 8-oxo-dGTP and 2-oxo-dATP, owing to its broad substrate specificity. MTH1 has also attracted attention as an anticancer target, and its substrate recognition is of biological and medical interest. Previous studies have suggested that MTH1 exhibits broad substrate specificity by changing the protonation states of Asp119 and Asp120 with high p

Indexed as

DNA Repair EnzymesPhosphoric Monoester HydrolasesPyrophosphatasesCatalytic DomainCrystallography, X-RayDeoxyguanine NucleotidesHumansModels, MolecularNeutronsNudix HydrolasesSubstrate Specificity8-oxodeoxyguanosine triphosphate8-oxodGTPaseDeoxyguanine NucleotidesDNA Repair EnzymesNudix HydrolasesPhosphoric Monoester HydrolasesPyrophosphatasesmetal-ion-dependent enzymeneutron crystallographyprotonationreaction mechanismtime-resolved X-ray crystallography

Identifiers

PMID40674425
PMCPMC12305053

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.